Abstract accepted at the American Society of Clinical Oncology (ASCO) Annual Meeting - the world’s largest and most ...

Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length ...

Bridge to Life™ Ltd., a global innovator in organ preservation solutions and perfusion technology, today announced the presentation of 12 accepted abstracts (five oral, including one Plenary Session ...

TOPEKA, Kan. (WIBW) - The Governor’s Water Conference will highlight the latest policy and research developments on water issues in Kansas. According to the Kansas Water Office, the 13th annual ...

The purpose of the event is to discuss and define the current role and future potential of technological, medical physics and molecular/biological innovations for routine clinical practice in ...

Advaxis, Inc.Diana Moore, 609-452-9814Director, Investor Relations & Business Development ., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced ...

~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform technology to systemically target medulloblastoma in vivo ~ ~ The GMAB platform ...

Preclinical research with VS-7375 in combination with PRMT5 inhibitors demonstrated strong durable tumor regressions in KRAS G12D pancreatic cancer models In preclinical pancreatic, lung, and ...

Contributions on the topics listed in the Conference Announcement under Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, ...